Adverum Biotechnologies's market cap is currently $82.79M. The company's EPS TTM is $-6.033; its P/E ratio is ―; Adverum Biotechnologies is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-1.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 3.60M	$ 0.00	$ 7.50M	$ 0.00	$ 250.00K
Gross Profit	$ -2.04M	$ -6.53M	$ 2.85M	$ -4.16M	$ 250.00K
Operating Income	$ -123.99M	$ -157.13M	$ -146.12M	$ -117.95M	$ -68.55M
EBITDA	$ -118.35M	$ -147.93M	$ -140.90M	$ -112.23M	$ -62.91M
Net Income	$ -117.17M	$ -154.54M	$ -145.54M	$ -117.51M	$ -64.49M
Balance Sheet
Cash & Short-Term Investments	$ 96.53M	$ 185.59M	$ 305.19M	$ 429.73M	$ 166.03M
Total Assets	$ 173.01M	$ 308.37M	$ 439.73M	$ 482.57M	$ 222.73M
Total Debt	$ 75.04M	$ 106.80M	$ 102.99M	$ 30.71M	$ 32.25M
Net Debt	$ 36.00K	$ 38.37M	$ 68.80M	$ -31.72M	$ -33.65M
Total Liabilities	$ 89.54M	$ 126.85M	$ 123.54M	$ 48.22M	$ 47.77M
Stockholders' Equity	$ 83.47M	$ 181.52M	$ 316.19M	$ 434.35M	$ 174.96M
Cash Flow
Free Cash Flow	$ -91.71M	$ -119.91M	$ -122.95M	$ -91.14M	$ -68.42M
Operating Cash Flow	$ -90.90M	$ -108.09M	$ -107.83M	$ -79.29M	$ -49.17M
Investing Cash Flow	$ 96.88M	$ 141.72M	$ 78.71M	$ -280.17M	$ -68.07M
Financing Cash Flow	$ 69.00K	$ 607.00K	$ 2.40M	$ 355.99M	$ 28.19M

Currency in USD

Adverum Biotechnologies Earnings and Revenue History

Income Statement >

Adverum Biotechnologies Debt to Assets

Balance Sheet >

Adverum Biotechnologies Cash Flow

Cash Flow >

Adverum Biotechnologies Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing